InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: sts66 post# 219484

Tuesday, 10/15/2019 2:28:16 PM

Tuesday, October 15, 2019 2:28:16 PM

Post# of 424416
In the supplemental analysis it shows -

• Non-alcoholic fatty liver disease (NAFLD) analyses using NAFLD Fibrosis Score (NFS), assessing – ITT Population:

o Effect on primary and key secondary composite endpoints by baseline NFS category, and,
o Treatment effect on change from baseline in NFS at 1 and 5 years
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News